[1] Abedizadeh R,Majidi F,Khorasani H R,et al.Colorectal cancer:A comprehensive review of carcinogenesis,diagnosis,and novel strategies for classified treatments[J].Cancer Metastasis Rev,2024,43(2):729-753. [2] Patel S G,Karlitz J J,Yen T,et al.The rising tide of early-onset colorectal cancer:A comprehensive review of epidemiology,clinical features,biology,risk factors,prevention,and earlydetection[J],Lancet Gastroenterol Hepatol.2022,7(3):262-274. [3] 黄理宾,黄秋实,杨烈.全球及中国的结直肠癌流行病学特征及防治:2022《全球癌症统计报告》解读[J].中国普外基础与临床杂志,2024,31(5):530-537. Huang L B,Huang Q S,Yang L.Global and Chinese epidemiological characteristics and prevention of colorectal cancer:Interpretation of the 2022 "Global Cancer Statistics Report"[J].Chin J Basic Clin Surg Gen Surg,2024,31(5):530-537. [4] O'Sullivan D E,Sutherland R L,Town S,et al.Risk factors for early-onset colorectal cancer:A systematic review and meta-analysis[J].Clin Gastroenterol Hepatol,2022,20(6):1229-1240. [5] 左晓彤,吴巧凤.肠道疾病与生物钟节律紊乱关系研究进展[J].实用医学杂志,2022,38(18):2363-2366. Zuo X T,Wu Q F.Research progress on the relationship between intestinal diseases and disruption of biological clockrhythms[J].J Pract Med,2022,38(18):2363-2366. [6] Lin Y,Wu S H,Wang X H,et al.Associations of imbalance of intestinal flora with severity of disease,inflammatory factors,adiponectin,and vascular endothelial function of hypertension patients[J].Kaohsiung J Med Sci,2022,38(2):165-173. [7] Patel R A,Panche A N,Harke S N.Gut microbiome-gut brain axis-depression:interconnection[J].World J Biol Psychiatry,2025,26(1):1-36. [8] 李慧玲,李晓曦,冯英楠,等.肠道菌群在肿瘤免疫治疗耐药中的作用机制研究进展[J].中国药理学通报,2025,41(1):1-6. Li H L,Li X X,Feng Y N,et al.Research progress on the mechanism of gut microbiota in tumor immunotherapy resistance[J].Chin J Phar,2025,41(1):1-6. [9] 张瑛,王园,库杰,等.老年结直肠癌术后感染病原菌及HMGB1/TLR4信号通路炎症因子表达水平[J].中华医院感染学杂志,2024,34(15):2347-2351. Zhang Y,Wang Y,Ku J,et al.Pathogenic bacteria causing postoperative infections in elderly patients with colorectal cancer and expression levels of inflammatory factors in the HMGB1/TLR4 signaling pathway[J].Chin J Hosp Infect,2024,34(15):2347-2351. [10] Ma Y,Gao F,Liu Y.CLK3 positively promoted colorectal cancer proliferation by activating IL-6/STAT3 signaling[J].Exp Cell Res,2024,440(1):114132. [11] 潘朝敏,戴靖萍,丁卓宇,等.早发性与晚发性结直肠癌临床特征比较及预后分析:一项基于SEER数据库的回顾性研究[J].现代消化及介入诊疗,2022,27(10):1253-1257. Pan Z M,Dai J P,Ding Z Y,et al.Comparison of clinical characteristics and prognosis of early-onset and late-onset colorectal cancer:A retrospective study based on the SEER database[J].Mode Diges Intervent Diag Treat,2022,27(10):1253-1257. [12] 中华人民共和国国家卫生健康委员会.中国结直肠癌诊疗规范(2020年版)[J].中华外科杂志,2020,58(8):561-585. The National Health Commission of the People's Republic of China.Chinese guidelines for the diagnosis and treatment of colorectal cancer(2020 Edition)[J].Chin J Surg,2020,58(8):561-585. [13] 张秀荣.肠道菌群粪便涂片检查图谱[M].第1版.北京:人民军医出版社,2000:27-61. Zhang X R.Microscopic examination of fecal samples for intestinalflora[M].1st edition.Beijing:People's Military Medical Press,2000:27-61. [14] Sohrab S S,Raj R,Nagar A,et al.Chronic inflammation's transformation to cancer:A nanotherapeutic paradigm[J].Molecules,2023,28(11):4413. [15] 褚立岩,莫毓,尹林,等.血清ITF3、HMGB1水平对结直肠癌患者根治术后早期炎性肠梗阻的诊断价值[J].标记免疫分析与临床,2023,30(12):2117-2122. Chu L Y,Mo Y,Yin L,et al.The diagnostic value of serum ITF3 and HMGB1 levels in early inflammatory intestinal obstruction after radical surgery in patients with colorectal cancer[J].Labeled Immunoassays Clin Med,2023,30(12):2117-2122. [16] Kasprzak A.The role of tumor microenvironment cells in colorectal cancer(CRC)cachexia[J].Int J Mol Sci,2021,22(4):1565. [17] 韩伟华,范忠臣,李扬,等.结直肠癌患者肠道菌群变化及其与血清炎性因子,病理分期关系[J].临床军医杂志,2024,52(6):641-643. Han W H,Fan Z C,Li Y,et al.Changes in the intestinal flora of patients with colorectal cancer and their relationship with serum inflammatory factors and pathological stage[J].Clin Milit Med J,2024,52(6):641-643. [18] Muñiz Pedrogo D A,Sears C L,Melia J M P.Colorectal cancer in inflammatory bowel disease:A review of the role of gut microbiota and bacterial biofilms in disease pathogenesis[J].J Crohns Colitis,2024,18(10):1713-1725. [19] Qu R,Zhang Y,Ma Y,et al.Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer[J].Adv Sci(Weinh),2023,10(23):e2205563. [20] Quaglio A E V,Grillo T G,De Oliveira E C S,et al.Gut microbiota,inflammatory bowel disease and colorectal cancer[J].World J Gastroenterol,2022,28(30):4053-4060. [21] Jasemi S,Molicotti P,Fais M,et al.Biological mechanisms of enterotoxigenic Bacteroides fragilis toxin:Linking inflammation,colorectal cancer,and clinical implications[J].Toxins(Basel),2025,17(6):305. [22] 钟润滔,黄丽芳,康玲,等.早发性结直肠癌的临床病理特征及预后生存分析[J].现代消化及介入诊疗,2025,30(6):668-672. Zhong R T,Huang L F,Kang L,et al.Clinical pathological characteristics and prognosis survival analysis of early-onset colorectal cancer[J].Mod J Digest Intervent Diag Treat,2025,30(6):668-672. [23] Di Vincenzo F,Del Gaudio A,Petito V,et al.Gut microbiota,intestinal permeability,and systemic inflammation:A narrative review[J].Intern Emerg Med,2024,19(2):275-293. [24] Zhang Z,Tanaka I,Pan Z,et al.Intestinal homeostasis and inflammation:Gut microbiota at the crossroads of pancreas-intestinal barrieraxis[J].Eur J Immunol,2022,52(7):1035-1046. [25] 蔺旺君,贾利丽.结直肠癌患者肠道菌群失调与血清炎性因子的相关性[J].中国微生态学杂志,2022,34(7):803-807. Lin W J,Jia L L.The correlation between intestinal flora imbalance in patients with colorectal cancer and serum inflammatory factors[J].Chin J Micr,2022,34(7):803-807. |